The novel GLP-1/GIP dual receptor agonist DA5-CH is superior to tirzepatide and exendin-4 in the 6-OHDA Parkinson rat model - Poll - MDSpire

The novel GLP-1/GIP dual receptor agonist DA5-CH is superior to tirzepatide and exendin-4 in the 6-OHDA Parkinson rat model

  • By

  • Zhang Lingyu

  • Feng Peng

  • Zhong Wanting

  • Jin Qianqian

  • Zijuan Zhang

  • Bo Bai

  • Guofang Xue

  • Christian Hölscher

  • May 5, 2026

  • 0 min

Share

Original Source(s)

The novel GLP-1/GIP dual receptor agonist DA5-CH is superior to tirzepatide and exendin-4 in the 6-OHDA Parkinson rat model

  • by Zhang Lingyu, Feng Peng, Zhong Wanting, Jin Qianqian, Zijuan Zhang, Bo Bai, Guofang Xue, Christian Hölscher

  • May 5, 2026

Related Content

Robotic arm vs. stereotactic frame in deep brain stimulation surgery for movement disorders: a retrospective cohort study

Cholinergic basal forebrain degeneration in isolated REM sleep behaviour disorder

Accessible assessment of motor and cognitive symptoms in Parkinson’s disease: integrating large datasets, machine-learning, and videoconferencing